stockmarketproxy
/
RVMDNasdaq,Nasdaq SEC EDGAR

Revolution Medicines, Inc.

Biological Products, (No Diagnostic Substances)·REDWOOD CITY, CA·FY end 12/31·CIK 1628171
OverviewFinancialsCompensationGovernanceInsidersFilings

Named Executive Officers

FY 2025
ExecutiveSalaryStockOptionsBonus / Inc.OtherTotal
Mark A. GoldsmithM.D., Ph.D.
$812.5K$4.0M$9.0M$889.7K$7.0K$14.7M
Stephen M. KelseyM.D., FRCP, FRCPath
$625.8K$1.5M$3.4M$461.2K$7.0K$6.0M
Margaret HornJ.D.
$582.7K$1.2M$2.6M$426.5K$7.0K$4.8M
Jeffrey Cislini
$523.8K$896.3K$2.0M$261.0K$7.0K$3.7M
Jack AndersChief Financial Officer
$523.3K$831.1K$1.9M$343.8K$7.0K$3.6M
General Counsel andSecretary
$477.2K$625.8K$1.4M$217.2K$7.0K$2.7M

CEO comp · median worker · ratio — multi-year trend

Need at least two fiscal years of proxy data to draw the trend line. The ingestion worker will populate prior-year proxies as it processes them.